Home
/ Antikor
/ Competitors

Antikor Competitors and Similar CompaniesClear all

Antikor's competitors and similar companies include Mersana Therapeutics, Dendreon and Legend Biotech.

	Antikor Antikor is a biotechnology company that specializes in the discovery and development of small-format antibody-drug conjugates.	Mersana Therapeutics Mersana Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugate (ADC) platforms.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.	Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date	Founding Date 2014	Founding Date 2005	Founding Date 1992	Founding Date 2014
Type	Type Private	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations Stevenage, GB HQ	Locations Cambridge, US HQ	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US	Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US
Employees	Employees 11	Employees 11033% increase	Employees 6131% decrease	Employees 2,90012% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 250.3 m	Valuation ($) N/A	Valuation ($) 8.4 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2025)
Net income	Net income N/A	Net income ($69.2m) (FY, 2024)	Net income N/A	Net income ($296.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 219.5m	Total funding raised N/A	Total funding raised $ 150.5m